A nurse is planning a staff education session regarding biological weapons of mass destruction. Which of the following should he plan to include in the session? (Select all that apply.)

Choice A: Ask the client to shrug his shoulders against passive resistance is not an assessment that will give the nurse information about the function of cranial nerve III. This assessment will test the function of cranial nerve XI, which is the accessory nerve. The accessory nerve innervates the trapezius and sternocleidomastoid muscles, which are involved in shoulder and neck movements.

Choice B: Instruct the client to look up and down without moving his head is an assessment that will give the nurse information about the function of cranial nerve III. Cranial nerve III is the oculomotor nerve, which innervates four of the six extraocular muscles that control eye movements. The oculomotor nerve also controls pupil size and lens shape. By instructing the client to look up and down without moving his head, the nurse can assess the ability of the oculomotor nerve to move the eyes vertically and adjust to different distances.

Choice C: Observe the client's ability to smile and frown is not an assessment that will give the nurse information about the function of cranial nerve III. This assessment will test the function of cranial nerve VII, which is the facial nerve. The facial nerve innervates the muscles of facial expression, which are involved in smiling, frowning, blinking, and other facial movements.

Choice D: Have the client stand with his eyes closed and touch his nose is not an assessment that will give the nurse information about the function of cranial nerve III. This assessment will test the function of cranial nerve VIII, which is the vestibulocochlear nerve. The vestibulocochlear nerve innervates the inner ear and is responsible for hearing and balance. By having the client stand with his eyes closed and touch his nose, the nurse can assess the ability of the vestibulocochlear nerve to maintain equilibrium and coordination.

Choice A reason: Vesicles on the skin are not typical of inhalation anthrax; instead, they are more associated with cutaneous anthrax, which presents as papules that progress to vesicles and then black eschars.

Choice B reason: Respiratory failure can occur later in the course of inhalation anthrax, but it is not an early finding. It usually develops after the initial phase of nonspecific symptoms when the illness progresses to severe respiratory distress and shock.

Choice C reason: Sloughing of skin is not characteristic of inhalation anthrax. Similar to vesicles, skin sloughing may be associated with severe cutaneous infections or other dermatologic conditions, not the respiratory form of anthrax.

Choice D reason: Flu-like symptoms, such as fever, cough, malaise, muscle aches, and mild chest discomfort, are the initial and most indicative early findings of inhalation anthrax. These nonspecific symptoms often appear within several days after exposure before progressing to severe respiratory compromise.